MDGL
Madrigal Pharmaceuticals Inc
NASDAQ: MDGL · HEALTHCARE · BIOTECHNOLOGY
$518.58
+0.37% today
Updated 2026-04-29
Market cap
$11.96B
P/E ratio
—
P/S ratio
12.48x
EPS (TTM)
$-12.87
Dividend yield
—
52W range
$265 – $615
Volume
0.4M
Madrigal Pharmaceuticals Inc (MDGL) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $743000.00 | $2.62M | $144.25M | $14.80M | $7.58M | $147000.00 | $0.00 | $0.00 | $0.00 | $0.00 | $350000.00 | $200000.00 | $0.00 | $21864.00 | $37318.00 | $0.00 | $0.00 | $180.13M | $958.40M |
| Revenue growth (YoY) | — | — | +252.0% | +5416.1% | -89.7% | -48.8% | -98.1% | -100.0% | — | — | — | — | -42.9% | -100.0% | — | +70.7% | -100.0% | — | — | +432.1% |
| Cost of revenue | $3.65M | — | — | — | — | $1.46M | $738000.00 | $516000.00 | $673000.00 | $0.00 | $156.00 | $77000.00 | $96000.00 | $112000.00 | $471000.00 | $405000.00 | $467000.00 | $527000.00 | $6.23M | $56.15M |
| Gross profit | $-3.65M | $743000.00 | $2.62M | $144.25M | $14.80M | $6.12M | $-738000.00 | $-516000.00 | $-673000.00 | $0.00 | $-156.00 | $350000.00 | $200000.00 | $-112000.00 | $21864.00 | $273000.00 | $-467000.00 | $-527000.00 | $173.90M | $902.25M |
| Gross margin | — | 100.0% | 100.0% | 100.0% | 100.0% | 80.7% | -502.0% | — | — | — | — | 100.0% | 100.0% | — | 100.0% | 731.6% | — | — | 96.5% | 94.1% |
| R&D | $50.50M | $52.02M | $81.58M | $51.05M | $40.25M | $41.46M | $49.41M | $71.86M | $68.20M | $54.22M | $15.93M | $24.39M | $25.39M | $72.32M | $184.81M | $205.16M | $245.44M | $272.35M | $236.72M | $388.52M |
| SG&A | $8.65M | $14.93M | $14.74M | $12.65M | $11.45M | $11.55M | $11.68M | $15.70M | $15.75M | $13.39M | $9.29M | $7.67M | $15.29M | $22.65M | $21.86M | $37.32M | $48.13M | $108.15M | $435.06M | $813.83M |
| Operating income | $-59.15M | $-66.22M | $-93.71M | $80.54M | $-36.90M | $-45.43M | $-61.09M | $-87.56M | $-83.95M | $-3.17M | $-25.22M | $-32.06M | $-40.68M | $-94.97M | $-206.67M | $-242.48M | $-293.57M | $-380.50M | $-497.88M | $-300.10M |
| Operating margin | — | -8912.0% | -3583.5% | 55.8% | -249.3% | -599.1% | -41556.5% | — | — | — | — | -9160.6% | -20341.0% | — | -945266.2% | -649772.2% | — | — | -276.4% | -31.3% |
| EBITDA | $-53.62M | $-60.14M | $-89.41M | $81.86M | $-34.97M | $-43.97M | $-60.20M | $-87.04M | $-83.28M | $-3.23M | $-25.22M | $-31.98M | $-40.59M | $-94.86M | $-206.20M | $-242.08M | $-290.92M | $-360.39M | $-450.13M | $-264.47M |
| EBITDA margin | — | -8094.8% | -3419.2% | 56.8% | -236.2% | -579.7% | -40954.4% | — | — | — | — | -9138.6% | -20293.0% | — | -943112.0% | -648687.0% | — | — | -249.9% | -27.6% |
| EBIT | $-57.27M | $-63.49M | $-92.13M | $79.40M | $-36.90M | $-45.43M | $-60.94M | $-87.56M | $-83.95M | $-3.24M | $-25.22M | $-32.06M | $-40.68M | $-94.97M | $-206.67M | $-242.48M | $-291.39M | $-360.92M | $-451.22M | $-265.98M |
| Interest expense | $0.00 | $0.00 | $489000.00 | $312000.00 | $569000.00 | $1.95M | $1.85M | $2.63M | $2.21M | $1.06M | $1.16M | $558000.00 | $7.67M | $11.02M | $4.33M | $1.04M | $3.96M | $12.71M | $14.67M | $22.31M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-57.27M | $-63.49M | $-92.62M | $79.09M | $-37.47M | $-47.38M | $-62.79M | $-90.19M | $-86.16M | $-6.84M | $-26.39M | $-31.15M | $-32.81M | $-72.81M | $-197.44M | $-241.08M | $-295.35M | $-373.63M | $-465.89M | $-288.28M |
| Net income growth (YoY) | — | -10.9% | -45.9% | +185.4% | -147.4% | -26.5% | -32.5% | -43.6% | +4.5% | +92.1% | -285.5% | -18.1% | -5.3% | -121.9% | -171.2% | -22.1% | -22.5% | -26.5% | -24.7% | +38.1% |
| Profit margin | — | -8545.8% | -3541.8% | 54.8% | -253.1% | -624.7% | -42714.3% | — | — | — | — | -8901.1% | -16405.5% | — | -903055.3% | -646010.0% | — | — | -258.6% | -30.1% |